Health care companies by P/E ratio
Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.
Charles River Laboratories International leads the 115 health care companies ranked by P/E ratio, at 358, ahead of Takeda Pharmaceutical (306) and Waters (192). Figures as of 19 Nov 2026, 18:12 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 115
- First
- Charles River Laboratories International358
- Median
- 30.2
- Combined market value
- CZK 199T
- Countries
- 14
- Not ranked
- 55no P/E ratio on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | P/E ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Charles River Laboratories InternationalCRL · Health Care | 358 | CZK 350.9B | CZK 7,323.16 | 1.27% down | 106% up | ||
| 2 | Takeda PharmaceuticalTAK · Health Care | 306 | CZK 1.52T | CZK 476.31 | 0.61% up | 51% up | ||
| 3 | WatersWAT · Health Care | 192 | CZK 2.01T | CZK 10,209.29 | 1.59% down | 23% up | ||
| 4 | Merck & CoMRK · Health Care | 134 | CZK 7.29T | CZK 2,955.13 | 3.64% down | 45% up | ||
| 5 | Ligand PharmaceuticalsLGND · Health Care | 116 | CZK 129B | CZK 6,448.11 | 3.01% down | 50% up | ||
| 6 | BiogenBIIB · Health Care | 107 | CZK 810.8B | CZK 5,485.14 | 1.98% down | 49% up | ||
| 7 | BillionToOneBLLN · Health Care | 99.3 | CZK 97.1B | CZK 2,033.00 | 0.22% down | 4% down | ||
| 8 | TG TherapeuticsTGTX · Health Care | 98.2 | CZK 221.4B | CZK 1,464.99 | 0.45% down | 117% up | ||
| 9 | SolventumSOLV · Health Care | 95.6 | CZK 321.7B | CZK 1,893.00 | 1.65% down | 9% up | ||
| 10 | Teva Pharmaceutical IndustriesTEVA · Health Care | 91.2 | CZK 1.02T | CZK 872.94 | 7.13% down | 74% up | ||
| 11 | MedlineMDLN · Health Care | 85.3 | CZK 1.1T | CZK 834.99 | 4.20% down | 4% down | ||
| 12 | PenumbraPEN · Health Care | 80.6 | CZK 280.8B | CZK 7,125.07 | 0.15% down | 15% up | ||
| 13 | TeleflexTFX · Health Care | 80.6 | CZK 144.5B | CZK 3,642.66 | 1.32% down | 58% up | ||
| 14 | ICONICLR · Health Care | 76.8 | CZK 320.2B | CZK 4,274.33 | 1.60% down | 23% up | ||
| 15 | LifeStance Health GroupLFST · Health Care | 73.8 | CZK 112.4B | CZK 295.58 | 3.56% down | 123% up | ||
| 16 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 71.8 | CZK 165.8B | CZK 2,110.34 | 0.25% down | 129% up | ||
| 17 | Jazz PharmaceuticalsJAZZ · Health Care | 71.1 | CZK 343.5B | CZK 5,350.81 | 2.97% down | 41% up | ||
| 18 | RevvityRVTY · Health Care | 68.1 | CZK 380.6B | CZK 3,408.96 | 0.48% up | 62% up | ||
| 19 | HeartflowHTFL · Health Care | 67.7 | CZK 88.8B | CZK 1,009.82 | 1.13% down | 66% up | ||
| 20 | Bio-TechneTECH · Health Care | 66.7 | CZK 254.2B | CZK 1,618.37 | 0.05% down | 24% up | ||
| 21 | Edwards LifesciencesEW · Health Care | 60.5 | CZK 1.33T | CZK 2,314.33 | 1.19% down | 25% up | ||
| 22 | IncyteINCY · Health Care | 59.2 | CZK 526.2B | CZK 2,581.31 | 1.55% down | 16% up | ||
| 23 | AlconALC · Health Care | 54.7 | CZK 801.9B | CZK 1,669.20 | 0.35% down | 0% up | ||
| 24 | Amneal PharmaceuticalsAMRX · Health Care | 53.4 | CZK 165.5B | CZK 474.98 | 2.47% down | 90% up | ||
| 25 | HaemoneticsHAE · Health Care | 52.9 | CZK 121.2B | CZK 2,661.28 | 2.68% down | 64% up | ||
| 26 | BeOne MedicinesONC · Health Care | 51.4 | CZK 1.02T | CZK 8,928.37 | 0.61% down | 16% up | ||
| 27 | Intuitive SurgicalISRG · Health Care | 49.8 | CZK 3.18T | CZK 9,159.41 | 2.24% down | 24% down | ||
| 28 | Corcept TherapeuticsCORT · Health Care | 48.8 | CZK 158.2B | CZK 1,445.40 | 4.20% down | 10% down | ||
| 29 | AbbVieABBV · Health Care | 48.6 | CZK 11.14T | CZK 6,301.10 | 1.02% down | 25% up | ||
| 30 | IDEXX LaboratoriesIDXX · Health Care | 46.4 | CZK 1.21T | CZK 15,333.30 | 1.37% down | 1% up | ||
| 31 | BrightSpring Health ServicesBTSG · Health Care | 45.8 | CZK 285.7B | CZK 1,435.83 | 5.60% down | 109% up | ||
| 32 | Royalty PharmaRPRX · Health Care | 44.5 | CZK 870.6B | CZK 1,514.18 | 0.93% down | 79% up | ||
| 33 | West Pharmaceutical ServicesWST · Health Care | 44.1 | CZK 608.6B | CZK 8,736.51 | 2.85% down | 57% up | ||
| 34 | GenmabGMAB · Health Care | 44.0 | CZK 706.8B | CZK 1,146.37 | 1.05% up | 70% up | ||
| 35 | Eli LillyLLY · Health Care | 43.9 | CZK 26.83T | CZK 30,121.97 | 2.13% down | 33% up | ||
| 36 | Krystal BiotechKRYS · Health Care | 43.0 | CZK 208.8B | CZK 7,044.50 | 0.37% up | 54% up | ||
| 37 | Becton, DickinsonBDX · Health Care | 42.1 | CZK 1.29T | CZK 4,737.06 | 1.50% down | 45% up | ||
| 38 | Dr. Reddy's LaboratoriesRDY · Health Care | 41.3 | CZK 276.1B | CZK 331.19 | 0.67% down | 8% up | ||
| 39 | Johnson & JohnsonJNJ · Health Care | 40.5 | CZK 14.29T | CZK 5,934.18 | 2.23% down | 34% up | ||
| 40 | PfizerPFE · Health Care | 39.5 | CZK 3.5T | CZK 614.86 | 1.55% down | 15% up | ||
| 41 | Abbott LaboratoriesABT · Health Care | 38.9 | CZK 4.01T | CZK 2,317.90 | 0.33% down | 16% down | ||
| 42 | DanaherDHR · Health Care | 37.6 | CZK 3.56T | CZK 5,054.01 | 0.66% down | 3% up | ||
| 43 | HumanaHUM · Health Care | 37.0 | CZK 1.02T | CZK 8,451.40 | 1.57% down | 73% up | ||
| 44 | Mettler-Toledo InternationalMTD · Health Care | 36.9 | CZK 753.3B | CZK 37,874.14 | 2.05% down | 24% up | ||
| 45 | Thermo Fisher ScientificTMO · Health Care | 36.5 | CZK 5.7T | CZK 15,386.61 | 0.21% down | 21% up | ||
| 46 | Cardinal HealthCAH · Health Care | 35.4 | CZK 1.41T | CZK 6,088.54 | 1.71% down | 34% up | ||
| 47 | Medpace HoldingsMEDP · Health Care | 35.3 | CZK 396.3B | CZK 14,166.12 | 1.61% down | 10% up | ||
| 48 | IlluminaILMN · Health Care | 35.1 | CZK 686B | CZK 4,536.97 | 2.94% down | 76% up | ||
| 49 | HealthEquityHQY · Health Care | 34.8 | CZK 177.6B | CZK 2,146.74 | 0.88% down | 3% down | ||
| 50 | Agilent TechnologiesA · Health Care | 34.7 | CZK 1.1T | CZK 3,918.21 | 0.73% down | 22% up | ||
| 51 | Vertex PharmaceuticalsVRTX · Health Care | 33.7 | CZK 2.96T | CZK 11,664.27 | 2.31% down | 27% up | ||
| 52 | StrykerSYK · Health Care | 33.5 | CZK 2.67T | CZK 7,002.88 | 1.11% down | 12% down | ||
| 53 | argenxARGX · Health Care | 32.6 | CZK 1.32T | CZK 20,951.43 | 0.01% up | 2% up | ||
| 54 | Merit Medical SystemsMMSI · Health Care | 31.8 | CZK 113.2B | CZK 1,889.44 | 1.21% down | 1% up | ||
| 55 | DexComDXCM · Health Care | 31.6 | CZK 665.7B | CZK 1,785.05 | 2.81% down | 41% up | ||
| 56 | IQVIA HoldingsIQV · Health Care | 30.7 | CZK 924.5B | CZK 5,609.78 | 2.25% down | 19% up | ||
| 57 | STERISSTE · Health Care | 30.3 | CZK 551.5B | CZK 5,679.33 | 1.70% down | 1% up | ||
| 58 | Labcorp HoldingsLH · Health Care | 30.2 | CZK 665.8B | CZK 8,199.89 | 0.64% down | 42% up | ||
| 59 | AvantorAVTR · Health Care | 30.1 | CZK 227.1B | CZK 335.17 | 2.03% down | 40% up | ||
| 60 | NovartisNVS · Health Care | 28.9 | CZK 6.37T | CZK 3,372.68 | 2.37% down | 25% up | ||
| 61 | McKessonMCK · Health Care | 27.3 | CZK 2.72T | CZK 23,560.68 | 2.39% down | 28% up | ||
| 62 | QiagenQGEN · Health Care | 26.7 | CZK 227.3B | CZK 1,100.86 | 0.20% down | 9% up | ||
| 63 | LivaNovaLIVN · Health Care | 26.6 | CZK 114B | CZK 2,068.61 | 1.69% down | 77% up | ||
| 64 | Ensign GroupENSG · Health Care | 26.6 | CZK 231.7B | CZK 3,972.07 | 2.47% down | 2% up | ||
| 65 | Protagonist TherapeuticsPTGX · Health Care | 26.4 | CZK 181.1B | CZK 2,774.17 | 1.98% down | 51% up | ||
| 66 | ChemedCHE · Health Care | 26.2 | CZK 158B | CZK 12,195.11 | 0.22% up | 27% up | ||
| 67 | Zimmer Biomet HoldingsZBH · Health Care | 26.0 | CZK 432.9B | CZK 2,287.51 | 0.53% down | 16% up | ||
| 68 | Quest DiagnosticsDGX · Health Care | 25.8 | CZK 635.1B | CZK 5,772.71 | 0.13% down | 38% up | ||
| 69 | Koninklijke PhilipsPHG · Health Care | 25.5 | CZK 638.9B | CZK 653.48 | 1.51% down | 12% up | ||
| 70 | AmgenAMGN · Health Care | 25.5 | CZK 5.3T | CZK 9,800.98 | 0.80% down | 32% up | ||
| 71 | Lantheus HoldingsLNTH · Health Care | 25.4 | CZK 148.6B | CZK 2,271.38 | 0.05% up | 90% up | ||
| 72 | AstraZenecaAZN · Health Care | 24.8 | CZK 6.05T | CZK 3,898.51 | 2.02% down | 1% up | ||
| 73 | MedtronicMDT · Health Care | 24.7 | CZK 2.87T | CZK 2,241.55 | 0.01% down | 1% up | ||
| 74 | Concentra Group Holdings ParentCON · Health Care | 24.5 | CZK 115.8B | CZK 921.46 | 1.23% down | 116% up | ||
| 75 | PACS GroupPACS · Health Care | 24.2 | CZK 150.5B | CZK 948.17 | 7.99% down | 77% up | ||
| 76 | Align TechnologyALGN · Health Care | 23.4 | CZK 251.9B | CZK 3,573.22 | 2.09% down | 23% up | ||
| 77 | Neurocrine BiosciencesNBIX · Health Care | 23.4 | CZK 354.7B | CZK 3,504.44 | 3.32% down | 17% up | ||
| 78 | Halozyme TherapeuticsHALO · Health Care | 23.1 | CZK 234.6B | CZK 2,057.93 | 3.49% down | 39% up | ||
| 79 | Henry ScheinHSIC · Health Care | 23.1 | CZK 207.3B | CZK 1,875.75 | 1.65% down | 20% up | ||
| 80 | Option Care HealthOPCH · Health Care | 22.9 | CZK 105.4B | CZK 703.56 | 0.32% down | 12% up | ||
| 81 | SanofiSNY · Health Care | 22.9 | CZK 2.46T | CZK 1,023.51 | 2.41% down | 4% down | ||
| 82 | MSA SafetyMSA · Health Care | 22.7 | CZK 151.8B | CZK 3,941.80 | 0.20% down | 16% up | ||
| 83 | InsuletPODD · Health Care | 22.4 | CZK 211.7B | CZK 3,052.06 | 2.04% down | 55% down | ||
| 84 | CenteneCNC · Health Care | 22.4 | CZK 717.3B | CZK 1,448.96 | 3.48% down | 94% up | ||
| 85 | ResMedRMD · Health Care | 21.6 | CZK 741.8B | CZK 5,273.58 | 2.34% down | 1% down | ||
| 86 | United TherapeuticsUTHR · Health Care | 21.3 | CZK 534.2B | CZK 12,543.66 | 2.39% down | 22% up | ||
| 87 | Encompass HealthEHC · Health Care | 21.1 | CZK 287.4B | CZK 2,928.64 | 2.48% down | 20% up | ||
| 88 | Regeneron PharmaceuticalsREGN · Health Care | 20.7 | CZK 2.16T | CZK 20,873.75 | 0.81% down | 28% up | ||
| 89 | Cooper CompaniesCOO · Health Care | 20.7 | CZK 254.8B | CZK 1,339.90 | 0.91% down | 15% down | ||
| 90 | Smith & NephewSNN · Health Care | 20.3 | CZK 278.3B | CZK 665.50 | 1.39% down | 5% down | ||
| 91 | ExelixisEXEL · Health Care | 19.8 | CZK 358.7B | CZK 1,470.11 | 3.28% down | 63% up | ||
| 92 | UnitedHealth GroupUNH · Health Care | 19.0 | CZK 6.65T | CZK 7,425.99 | 4.65% down | 12% up | ||
| 93 | CencoraCOR · Health Care | 19.0 | CZK 1.45T | CZK 7,596.26 | 2.02% down | 4% down | ||
| 94 | Boston ScientificBSX · Health Care | 18.2 | CZK 1.39T | CZK 962.19 | 0.94% down | 55% down | ||
| 95 | GE HealthCare TechnologiesGEHC · Health Care | 17.3 | CZK 825.7B | CZK 1,826.12 | 1.93% down | 12% up | ||
| 96 | Ascendis PharmaASND · Health Care | 17.1 | CZK 379.3B | CZK 5,781.83 | 3.91% down | 29% up | ||
| 97 | Globus MedicalGMED · Health Care | 17.0 | CZK 204.1B | CZK 1,540.66 | 1.86% down | 14% down | ||
| 98 | GSKGSK · Health Care | 16.7 | CZK 2.14T | CZK 1,067.58 | 1.27% down | 5% up | ||
| 99 | Elevance HealthELV · Health Care | 16.6 | CZK 1.88T | CZK 8,709.43 | 2.38% down | 28% up | ||
| 100 | HCA HealthcareHCA · Health Care | 15.3 | CZK 2.15T | CZK 10,300.10 | 2.85% down | 0% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2575 CZK). 55 companies have no P/E ratio on file and are not ranked here.
Questions and answers
Which health care companies rank first by P/E ratio?
Charles River Laboratories International (358), Takeda Pharmaceutical (306) and Waters (192) are the top three of the 115 health care companies ranked by P/E ratio as of 19 Nov 2026, 18:12 UTC.
How many health care companies are in this ranking?
115 are ranked by P/E ratio. 55 more have no P/E ratio on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 115 health care companies ranked by P/E ratio have a combined market value of CZK 199T as of 19 Nov 2026, 18:12 UTC.
What does ranking by P/E ratio measure?
Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- PEG ratio: P/E adjusted for growth, and its limits
The PEG ratio is a stock's P/E divided by its expected yearly earnings growth in percent. A P/E of 20 with 10% expected growth gives a PEG of 2; with 20% growth, a PEG of 1. A PEG near 1 is the traditional rough mark of a fair price, but the growth figure is a forecast and often wrong.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies by P/E ratio”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=pe-ratio
Underlying data: Yahoo Finance; SEC EDGAR.